These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12677480)

  • 21. Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression.
    Setzer M; Hermann E; Seifert V; Marquardt G
    Spine (Phila Pa 1976); 2008 Mar; 33(5):497-502. PubMed ID: 18317192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-DR,DQ and APOE genotypes and gender influence in Sardinian primary progressive MS.
    Cocco E; Sotgiu A; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Contu P; Marrosu MG
    Neurology; 2005 Feb; 64(3):564-6. PubMed ID: 15699400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of apolipoprotein E polymorphism on renal transplantation.
    Cofán F; Cofan M; Rosich E; Campos B; Casals E; Zambon D; Ros E; Oppenheimer F; Campistol JM
    Transplant Proc; 2007 Sep; 39(7):2217-8. PubMed ID: 17889142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E polymorphism is not associated with spinal bone mineral density in peri- and postmenopausal Greek women.
    Efstathiadou Z; Koukoulis G; Stakias N; Challa A; Tsatsoulis A
    Maturitas; 2004 Jul; 48(3):259-64. PubMed ID: 15207892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.
    Sena A; Couderc R; Ferret-Sena V; Pedrosa R; Andrade ML; Araujo C; Roque R; Cascais MJ; Morais MG
    Eur J Neurol; 2009 Jul; 16(7):832-7. PubMed ID: 19473356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of relapse rate in MS clinical trials.
    Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
    Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No association of apolipoprotein E epsilon4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis.
    Sedano MI; Calmarza P; Perez L; Trejo JM
    Mult Scler; 2006 Feb; 12(1):13-8. PubMed ID: 16459715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
    Ramagopalan SV; Deluca GC; Morrison KM; Herrera BM; Dyment DA; Orton S; Bihoreau MT; Degenhardt A; Pugliatti M; Sadovnick AD; Sotgiu S; Ebers GC
    J Neuroimmunol; 2007 May; 186(1-2):156-60. PubMed ID: 17376543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
    Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
    Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction.
    Gromadzka G; Baranska-Gieruszczak M; Sarzynska-Dlugosz I; Ciesielska A; Czlonkowska A
    Acta Neurol Scand; 2007 Dec; 116(6):392-8. PubMed ID: 17986098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Age-related macular degeneration: its association with the epsilon4 allele of the apolipoprotein E gene].
    Asensio-Sánchez VM; Rodríguez-Martín T; Gala-Molina I; Rodríguez-Fernández I
    Arch Soc Esp Oftalmol; 2006 Jan; 81(1):9-12. PubMed ID: 16450255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients.
    Ely EW; Girard TD; Shintani AK; Jackson JC; Gordon SM; Thomason JW; Pun BT; Canonico AE; Light RW; Pandharipande P; Laskowitz DT
    Crit Care Med; 2007 Jan; 35(1):112-7. PubMed ID: 17133176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic polymorphism of the E apolipoprotein in school age children: comparison with levels of plasma lipids and apolipoproteins].
    Callas N; Poveda E; Baracaldo C; Hernández P; Castillo C; Guerra M
    Biomedica; 2007 Dec; 27(4):526-36. PubMed ID: 18320120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
    Beyer K; Lao JI; Latorre P; Ariza A
    Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.